Skip to main content
Journal cover image

Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss.

Publication ,  Journal Article
Bao, J; Hungerford, M; Luxmore, R; Ding, D; Qiu, Z; Lei, D; Yang, A; Liang, R; Ohlemiller, KK
Published in: Hear Res
October 2013

Noise is the most common occupational and environmental hazard. Noise-induced hearing loss (NIHL) is the second most common form of sensorineural hearing deficit, after age-related hearing loss (presbycusis). Although promising approaches have been identified for reducing NIHL, currently there are no effective medications to prevent NIHL. Development of an efficacious treatment has been hampered by the complex array of cellular and molecular pathways involved in NIHL. We turned this difficulty into an advantage by asking whether NIHL could be effectively prevented by targeting multiple signaling pathways with a combination of drugs already approved by U.S. Food and Drug Administration (FDA). We previously found that antiepileptic drugs blocking T-type calcium channels had both prophylactic and therapeutic effects for NIHL. NIHL can also be reduced by an up-regulation of glucocorticoid (GC) signaling pathways. Based on these findings, we tested a combination therapy for NIHL that included ethosuximide and zonisamide (anticonvulsants) and dexamethasone and methylprednisolone (synthetic GCs) in mice under exposure conditions typically associated with dramatic permanent threshold shifts (PTS). We first examined possible prophylactic effects for each drug when administered alone 2 h before noise, and calculated the median effective dose (ED50). We then tested for synergistic effects of two-drug combinations (anticonvulsant + GC), and identified combinations with the strongest synergy against NIHL, based on a previously established combination index (CI) metric. We repeated similar tests to determine their therapeutic effects when administered the same drugs 24 h after the noise exposure. Our study shows the feasibility of developing pharmacological intervention in multiple pathways, and discovering drug combinations with optimal synergistic effects in preventing permanent NIHL.

Duke Scholars

Published In

Hear Res

DOI

EISSN

1878-5891

Publication Date

October 2013

Volume

304

Start / End Page

33 / 40

Location

Netherlands

Related Subject Headings

  • Zonisamide
  • Otorhinolaryngology
  • Mice, Inbred C57BL
  • Mice
  • Methylprednisolone
  • Male
  • Isoxazoles
  • Hearing Loss, Noise-Induced
  • Glucocorticoids
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bao, J., Hungerford, M., Luxmore, R., Ding, D., Qiu, Z., Lei, D., … Ohlemiller, K. K. (2013). Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss. Hear Res, 304, 33–40. https://doi.org/10.1016/j.heares.2013.06.004
Bao, Jianxin, Michelle Hungerford, Randi Luxmore, Dalian Ding, Ziyu Qiu, Debin Lei, Aizhen Yang, Ruqiang Liang, and Kevin K. Ohlemiller. “Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss.Hear Res 304 (October 2013): 33–40. https://doi.org/10.1016/j.heares.2013.06.004.
Bao J, Hungerford M, Luxmore R, Ding D, Qiu Z, Lei D, et al. Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss. Hear Res. 2013 Oct;304:33–40.
Bao, Jianxin, et al. “Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss.Hear Res, vol. 304, Oct. 2013, pp. 33–40. Pubmed, doi:10.1016/j.heares.2013.06.004.
Bao J, Hungerford M, Luxmore R, Ding D, Qiu Z, Lei D, Yang A, Liang R, Ohlemiller KK. Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss. Hear Res. 2013 Oct;304:33–40.
Journal cover image

Published In

Hear Res

DOI

EISSN

1878-5891

Publication Date

October 2013

Volume

304

Start / End Page

33 / 40

Location

Netherlands

Related Subject Headings

  • Zonisamide
  • Otorhinolaryngology
  • Mice, Inbred C57BL
  • Mice
  • Methylprednisolone
  • Male
  • Isoxazoles
  • Hearing Loss, Noise-Induced
  • Glucocorticoids
  • Female